Cart
sales@molnova.com
Eciruciclib
CAS No. 1868086-40-1
Eciruciclib( —— )
Catalog No. M28496 CAS No. 1868086-40-1
Eciruciclib is an inhibitor of CDK with antitumor properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 198 | In Stock |
|
| 10MG | 299 | In Stock |
|
| 25MG | 509 | In Stock |
|
| 50MG | 686 | In Stock |
|
| 100MG | 910 | In Stock |
|
| 200MG | 1200 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEciruciclib
-
NoteResearch use only, not for human use.
-
Brief DescriptionEciruciclib is an inhibitor of CDK with antitumor properties.
-
DescriptionEciruciclib is an inhibitor of CDK with antitumor properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1868086-40-1
-
Formula Weight488.6
-
Molecular FormulaC27H33FN8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2 mg/mL (4.09 mM)
-
SMILESCC(C1=C2C=C(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)C=CC2=NN1C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
ML365
ML365 is a novel selective small molecule inhibitor of TASK1(KCNK3).
-
Senexin-A
A selective inhibitor of CDK8 (IC50=0.28 uM) and CDK19; inhibits CDK8 and CDK19 ATP site binding with Kd50 of 0.83 uM and 0.31 uM, respectively.
-
Kenpaullone
Kenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM).
